{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:06:08Z","timestamp":1747181168458,"version":"3.40.5"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Key Natural Science Project of the Anhui Provincial Department of Education","award":["2023AH050774"],"award-info":[{"award-number":["2023AH050774"]}]},{"name":"the Self-Funded Project of the University-Level Scientific Research Institute of Anhui University of Chinese Medicine","award":["2020ybzc03"],"award-info":[{"award-number":["2020ybzc03"]}]},{"name":"the High-Level Talent Support Program of Anhui University of Chinese Medicine","award":["2022rcyb021"],"award-info":[{"award-number":["2022rcyb021"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,29]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>To evaluate the short-term efficacy of denervation in treating hypertension with the exclusion of drug-interfering factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>An electronic search was conducted across 8 databases, including MEDLINE, PubMed, Cochrane Library, and EMBASE, for articles on denervation in the treatment of medication-na\u00efve hypertension published from inception to May 2024. All data were meta-analyzed using RevMan 5.3 software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Four studies, comprising a total of 752 subjects, were screened according to the inclusion and exclusion criteria. Meta-analysis indicated that, compared to the sham-operated group, the denervation group showed a significant reduction in short-term 24-hour ambulatory systolic blood pressure and office systolic blood pressure (OSBP) as well as office diastolic blood pressure (ODBP). No significant safety events were identified.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Denervation has the potential to reduce blood pressure in the short-term for patients with medication-na\u00efve hypertension, demonstrating an acceptable safety profile. This offers hope for patients who are intolerant to drug therapy or unwilling to take lifelong medication. However, its long-term effects require further study. Future research should focus on expanding the sample size and prolonging the follow-up period to further solidify its role in the treatment of hypertension.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040705","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T21:03:54Z","timestamp":1732914234000},"page":"e40705","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Short-term effects of denervation in the treatment of hypertension: A meta-analysis excluding drug interferences"],"prefix":"10.1097","volume":"103","author":[{"given":"Yimu","family":"Wang","sequence":"first","affiliation":[{"name":"College of Nursing, Anhui University of Chinese Medicine, Hefei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyu","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Nursing, Anhui University of Chinese Medicine, Hefei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyu","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Nursing, Anhui University of Chinese Medicine, Hefei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Nursing, Anhui University of Chinese Medicine, Hefei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Nursing, Anhui University of Chinese Medicine, Hefei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6825-5460","authenticated-orcid":false,"given":"Haiyan","family":"Fang","sequence":"additional","affiliation":[{"name":"College of Nursing, Anhui University of Chinese Medicine, Hefei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","first-page":"414","article-title":"[Arterial hypertension].","volume":"147","author":"Hengel","year":"2022","journal-title":"Dtsch Med Wochenschr"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11906-016-0642-9","article-title":"Hypertension, blood pressure variability, and target organ lesion.","volume":"18","author":"Irigoyen","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/S0140-6736(17)32478-9","article-title":"Prevalence, awareness, treatment, and control of hypertension in China: data from 1\u00b77 million adults in a population-based screening study (China PEACE Million Persons Project).","volume":"390","author":"Lu","year":"2017","journal-title":"Lancet (London, England)"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/eurheartj\/ehad054","article-title":"Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC council on hypertension and the European Association of percutaneous cardiovascular interventions (EAPCI).","volume":"44","author":"Barbato","year":"2023","journal-title":"Eur Heart J"},{"key":"R6-20250503","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions.","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcin.2019.10.061","article-title":"The REDUCE HTN: REINFORCE: randomized, sham-controlled trial of bipolar radiofrequency renal denervation for the treatment of hypertension.","volume":"13","author":"Weber","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","article-title":"Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.","volume":"391","author":"Azizi","year":"2018","journal-title":"Lancet (London, England)"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","article-title":"Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.","volume":"395","author":"B\u00f6hm","year":"2020","journal-title":"Lancet"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.2023.0713","article-title":"Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial.","volume":"329","author":"Azizi","year":"2023","journal-title":"JAMA"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.2019.9811","article-title":"Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes.","volume":"322","author":"Yang","year":"2019","journal-title":"JAMA"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b725 million people.","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/HYPERTENSIONAHA.120.14591","article-title":"Ambulatory blood pressure monitoring to diagnose and manage hypertension.","volume":"77","author":"Huang","year":"2021","journal-title":"Hypertension"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2014.07.021","article-title":"Ambulatory blood pressure monitoring in clinical practice: a review.","volume":"128","author":"Turner","year":"2015","journal-title":"Am J Med"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"e026582","DOI":"10.1161\/JAHA.122.026582","article-title":"Global Burden, regional differences, trends, and health consequences of medication nonadherence for hypertension during 2010 to 2020: a meta-analysis involving 27 Million Patients.","volume":"11","author":"Lee","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension.","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1097\/01.hjh.0000913472.77433.c2","article-title":"The impact of renal denervation procedure on the use of antihypertensive drugs. A real-life investigation from italy.","volume":"41","author":"Rea","year":"2023","journal-title":"J Hypertens"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/HYPERTENSIONAHA.123.21283","article-title":"Outcomes following radiofrequency renal denervation according to antihypertensive medications: subgroup analysis of the global SYMPLICITY Registry DEFINE.","volume":"80","author":"Mahfoud","year":"2023","journal-title":"Hypertension"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","article-title":"Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.","volume":"59","author":"Brandt","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2018.03.022","article-title":"Effects of renal sympathetic denervation on myocardial structure, function and perfusion: a serial CMR study.","volume":"272","author":"Delacroix","year":"2018","journal-title":"Atherosclerosis"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/14017431.2022.2084562","article-title":"Quality of life following renal sympathetic denervation in treatment-resistant hypertensive patients: a two-year follow-up study.","volume":"56","author":"Hanssen","year":"2022","journal-title":"Scand Cardiovasc J"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2012.07.029","article-title":"Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.","volume":"60","author":"Geisler","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1113\/expphysiol.2014.079871","article-title":"Reinnervation following catheter-based radio-frequency renal denervation.","volume":"100","author":"Booth","year":"2015","journal-title":"Exp Physiol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/08037051.2020.1828818","article-title":"The randomised Oslo study of renal denervation vs. antihypertensive drug adjustments: efficacy and safety through 7 years of follow-up.","volume":"30","author":"Bergland","year":"2021","journal-title":"Blood Press"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:03:03Z","timestamp":1746316983000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":24,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040705","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,11,29]]}}}